RESUMEN
BACKGROUND: Well-being outcomes for parents of children with intellectual and developmental disabilities (IDD) may vary from positive to negative at different times and for different measures of well-being. Predicting and explaining this variability has been a major focus of family research for reasons that have both theoretical and applied implications. METHODS: The current study used data from a 23-year longitudinal investigation of adoptive and birth parents of children with IDD to determine which early child, mother and family characteristics would predict the variance in maternal outcomes 20 years after their original measurement. Using hierarchical regression analyses, we tested the predictive power of variables measured when children were 7 years old on outcomes of maternal well-being when children were 26 years old. Outcome variables included maternal self-report measures of depression and well-being. RESULTS: Final models of well-being accounted for 20% to 34% of variance. For most outcomes, Family Accord and/or the personality variable of Neuroticism (emotional stability/instability) were significant predictors, but some variables demonstrated a different pattern. CONCLUSIONS: These findings confirm that (1) characteristics of the child, mother and family during childhood can predict outcomes of maternal well-being 20 years later; and (2) different predictor-outcome relationships can vary substantially, highlighting the importance of using multiple measures to gain a more comprehensive understanding of maternal well-being. These results have implications for refining prognoses for parents and for tailoring service delivery to individual child, parent and family characteristics.
Asunto(s)
Discapacidades del Desarrollo/enfermería , Relaciones Familiares/psicología , Discapacidad Intelectual/enfermería , Madres/psicología , Satisfacción Personal , Personalidad/fisiología , Adolescente , Adulto , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto JovenRESUMEN
The regulatory agencies' main responsibility regarding the marketing of veterinary medicinal products is to ensure that the products have a marketing authorisation with specific conditions of use adequate to ensure the quality, safety and efficacy of the product under consideration. In addition, control and surveillance systems are necessary to allow monitoring of the product after it has been authorised. In respectto antimicrobials, specific consideration must be given to minimising resistance development and retaining the effectiveness of these drugs for the treatment of humans and animals. Surveillance programmes should be in place to follow trends in resistance development, as well as in the consumption of veterinary antimicrobials, in order to provide for science-based policy recommendations regarding public and animal health.
Asunto(s)
Antiinfecciosos , Control de Medicamentos y Narcóticos/organización & administración , Comercialización de los Servicios de Salud , Drogas Veterinarias , Animales , Antiinfecciosos/economía , Antiinfecciosos/normas , Antiinfecciosos/uso terapéutico , Residuos de Medicamentos , Farmacorresistencia Microbiana , Guías como Asunto , Humanos , Comercialización de los Servicios de Salud/organización & administración , Comercialización de los Servicios de Salud/normas , Drogas Veterinarias/economía , Drogas Veterinarias/normas , Drogas Veterinarias/uso terapéuticoRESUMEN
Advanced technologies and regulatory regimes have contributed to the availability of veterinary vaccines that have high quality and favourable safety profiles in terms of potential risks posed to the target animals, the persons who come into contact with the vaccine, the consumers of food derived from vaccinated animals and the environment. The authorisation process requires that a range of safety studies are provided to evaluate the products. The design and production of vaccines, and their safe use, are primarily assessed by using data gathered from extensive pre-marketing studies performed on target animals and specific quality tests. The current post-marketing safeguards include good manufacturing practices, batch safety testing, inspections and pharmacovigilance. In addition to hazard identification, a full benefit/risk evaluation needs to be undertaken. The outcome of that evaluation will determine options for risk management and affect regulatory decisions on the safety of the vaccine; options might, for example, include special warnings on package inserts and labels.
Asunto(s)
Seguridad de Productos para el Consumidor , Legislación Alimentaria , Legislación Veterinaria , Vacunación/veterinaria , Animales , Control de Medicamentos y Narcóticos , Humanos , Carne/normas , Guías de Práctica Clínica como Asunto , Medición de Riesgo , Vacunación/efectos adversos , Vacunación/legislación & jurisprudencia , Vacunación/normasRESUMEN
The functional coupling of protein synthesis and chaperone-assisted folding in vivo has remained largely unexplored. Here we have analysed the chaperonin-dependent folding pathway of actin in yeast. Remarkably, overexpression of a heterologous chaperonin which traps non-native polypeptides does not interfere with protein folding in the cytosol, indicating a high-level organization of folding reactions. Newly synthesized actin avoids the chaperonin trap and is effectively channelled from the ribosome to the endogenous chaperonin TRiC. Efficient actin folding on TRiC is critically dependent on the hetero-oligomeric co-chaperone GimC. By interacting with folding intermediates and with TRiC, GimC accelerates actin folding at least 5-fold and prevents the premature release of non-native protein from TRiC. We propose that TRiC and GimC form an integrated 'folding compartment' which functions in cooperation with the translation machinery. This compartment sequesters newly synthesized actin and other aggregation-sensitive polypeptides from the crowded macromolecular environment of the cytosol, thereby allowing their efficient folding.
Asunto(s)
Actinas/química , Actinas/metabolismo , Chaperoninas/metabolismo , Péptidos y Proteínas de Señalización Intracelular , Proteínas Asociadas a Microtúbulos , Pliegue de Proteína , Saccharomyces cerevisiae/metabolismo , Actinas/genética , Animales , Bovinos , Compartimento Celular , Chaperonina 60/química , Chaperonina 60/genética , Chaperonina 60/metabolismo , Chaperoninas/química , Chaperoninas/genética , Citosol/metabolismo , Técnicas In Vitro , Sustancias Macromoleculares , Masculino , Proteínas Nucleares/química , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Saccharomyces cerevisiae/genética , Ubiquitina-Proteína Ligasas , Región del Complejo T del GenomaAsunto(s)
Antineoplásicos/farmacología , Inhibidores Enzimáticos/farmacología , Inmunosupresores/farmacología , Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH , Oxidorreductasas/metabolismo , Animales , Dihidroorotato Deshidrogenasa , Diseño de Fármacos , Humanos , Inmunoglobulinas , Modelos Biológicos , Oxidorreductasas/antagonistas & inhibidores , Oxidorreductasas/inmunología , Pirimidinas/biosíntesis , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/metabolismoRESUMEN
Previously, we have shown that the gamma-tubulin Tub4p and the spindle pole body component Spc98p are involved in microtubule organization by the yeast microtubule organizing centre, the spindle pole body (SPB). In this paper we report the identification of SPC97 encoding an essential SPB component that is in association with the SPB substructures that organize the cytoplasmic and nuclear microtubules. Evidence is provided for a physical and functional interaction between Tub4p, Spc98p and Spc97p: first, temperature-sensitive spc97(ts) mutants are suppressed by high gene dosage of SPC98 or TUB4. Second, Spc97p interacts with Spc98p and Tub4p in the two-hybrid system. Finally, immunoprecipitation and fractionation studies revealed complexes containing Tub4p, Spc98p and Spc97p. Further support for a direct interaction of Tub4p, Spc98p and Spc97p comes from the toxicity of strong SPC97 overexpression which is suppressed by co-overexpression of TUB4 or SPC98. Analysis of temperature-sensitive spc97(ts) alleles revealed multiple spindle defects. While spc97-14 cells are either impaired in SPB separation or mitotic spindle formation, spc97-20 cells show an additional defect in SPB duplication. We discuss a model in which the Tub4p-Spc98p-Spc97p complex is part of the microtubule attachment site at the SPB.
Asunto(s)
Proteínas Asociadas a Microtúbulos/metabolismo , Microtúbulos/fisiología , Saccharomyces cerevisiae/fisiología , Huso Acromático/fisiología , Tubulina (Proteína)/metabolismo , Clonación Molecular , Genotipo , Proteínas Asociadas a Microtúbulos/biosíntesis , Microtúbulos/ultraestructura , Sistemas de Lectura Abierta , Plásmidos , Proteínas Recombinantes/metabolismo , Proteínas Represoras/metabolismo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/ultraestructura , Huso Acromático/ultraestructuraRESUMEN
Yeast calmodulin (CaM) was found to be localized to the microtubule organizing centre, the spindle pole body. The spindle pole body is a multi-layered structure consisting of outer, central and inner plaques. In this paper, we report that a fraction of CaM is in association with the central plaque of the spindle pole body. This localization is dependent on the calmodulin-binding site of another spindle pole body component, Spc110p, which serves as a spacer connecting the inner plaque with the central plaque. Since the CaM-binding site of Spc110p is located near the carboxy terminus, Spc110p-dependent localization of calmodulin defines the orientation of Spc110p with the carboxy terminus towards the central plaque and the amino terminus towards the inner plaque. This orientation of Spc110p was confirmed using antibodies specific for the amino-terminal end of Spc110p, which predominantly labelled the inner plaque. In addition, synthetic peptides corresponding to the calmodulin-binding site of Spc110p bound to calmodulin with a Kd in the nanomolar range and nearly independent of Ca2+.
Asunto(s)
Calmodulina/metabolismo , Centrosoma/metabolismo , Proteínas Fúngicas/metabolismo , Proteínas Nucleares/metabolismo , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/metabolismo , Secuencia de Aminoácidos , Sitios de Unión , Calcio/metabolismo , Proteínas de Unión a Calmodulina , Centrosoma/ultraestructura , Proteínas del Citoesqueleto , Cartilla de ADN/genética , Proteínas Fúngicas/química , Microscopía Inmunoelectrónica , Datos de Secuencia Molecular , Proteínas Nucleares/química , Péptidos/química , Péptidos/metabolismo , Unión Proteica , Saccharomyces cerevisiae/ultraestructuraRESUMEN
Centrins are a subfamily within the superfamily of Ca2+-modulated proteins that play a fundamental role in centrosome duplication and contraction of centrin-based fiber systems. We examined the individual molecular properties of yeast, green alga, and human centrins. Circular dichroism spectroscopy revealed a divergent influence of Ca2+ binding on the alpha-helical content of these proteins. Ca2+-free centrins were elongated in shape as determined by size exclusion chromatography. The presence of Ca2+ and binding peptide resulted in more spherical shaped centrins. In contrast to yeast calmodulin, centrins formed multimers in the Ca2+-bound state. This oligomerization was significantly reduced in the absence of Ca2+ and in the presence of binding peptide. The Ca2+-dependent polymerization of the green alga Scherffelia dubia centrin (SdCen) resulted in a filamentous network. This molecular property was mainly dependent on the amino-terminal subdomain and the peptide-binding site of SdCen. Finally, we analyzed whether SdCen and Cdc31p-SdCen hybrid proteins functionally substitute for the Saccharomyces cerevisiae centrin Cdc31p. Only hybrid proteins containing the amino-terminal subdomain or the third EF-hand of SdCen and the other subdomains from Cdc31p were functional in vivo.
Asunto(s)
Proteínas de Unión al Calcio/química , Proteínas Cromosómicas no Histona , Proteínas Contráctiles/química , Proteínas de Saccharomyces cerevisiae , Secuencia de Aminoácidos , Secuencia de Bases , Sitios de Unión , Unión Competitiva , Calcio/metabolismo , Calmodulina/química , Proteínas de Ciclo Celular/química , Chlorophyta , Cromatografía en Gel , Dicroismo Circular , Humanos , Datos de Secuencia Molecular , Peso Molecular , Unión Proteica , Conformación Proteica , Estructura Secundaria de Proteína , Saccharomyces cerevisiae , Homología de Secuencia de Aminoácido , Relación Estructura-ActividadRESUMEN
Tub4p is a novel tubulin in Saccharomyces cerevisiae that most closely resembles gamma-tubulin. We report in this manuscript that the essential Tub4p is associated with the inner and outer plaques of the yeast microtubule organizing center, the spindle pole body (SPB). These SPB substructures are involved in the attachment of the nuclear and cytoplasmic microtubules, respectively (Byers, B., and L. Goetsch. 1975. J. Bacteriol. 124:511-523). Study of a temperature sensitive tub4-1 allele revealed that TUB4 has essential functions in microtubule organization. Remarkably, SPB duplication and separation are not impaired in tub4-1 cells incubated at the nonpermissive temperature. However, SPBs from such cells contain less or misdirected nuclear microtubules. Further analysis revealed that tub4-1 cells are able to assemble a short bipolar spindle, suggesting that the defect in microtubule organization occurs after spindle formation. A role of Tub4p in microtubule organization is further suggested by an increase in chromosome loss in tub4-1 cells. In addition, cell cycle arrest and survival of tub4-1 cells is dependent on the mitotic checkpoint control gene BUB2 (Hoyt, M.A., L. Totis, B.T. Roberts. 1991. Cell. 66:507-517), one of the cell's monitors of spindle integrity.
Asunto(s)
Proteínas de Ciclo Celular , Proteínas Fúngicas/metabolismo , Microtúbulos/metabolismo , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/metabolismo , Huso Acromático/metabolismo , Tubulina (Proteína)/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Ciclo Celular/genética , Cromosomas Fúngicos , ADN de Hongos , Proteínas Fúngicas/genética , Prueba de Complementación Genética , Datos de Secuencia Molecular , Saccharomyces cerevisiae/genética , Transducción de Señal , Tubulina (Proteína)/genética , Xenopus laevisRESUMEN
KAR1 has been identified as an essential gene which is involved in karyogamy of mating yeast cells and in spindle pole body duplication of mitotic cells (Rose, M. D., and G. R. Fink. 1987. Cell. 48:1047-1060). We investigated the cell cycle-dependent localization of the Kar1 protein (Kar1p) and its interaction with other SPB components. Kar1p is associated with the spindle pole body during the entire cell cycle of yeast. Immunoelectron microscopic studies with anti-Kar1p antibodies or with the monoclonal antibody 12CA5 using an epitope-tagged, functional Kar1p revealed that Kar1p is associated with the half bridge or the bridge of the spindle pole body. Cdc31p, a Ca(2+)-binding protein, was previously identified as the first component of the half bridge of the spindle pole body (Spang, A., I. Courtney, U. Fackler, M. Matzner, and E. Schiebel. 1993. J. Cell Biol. 123:405-416). Using an in vitro assay we demonstrate that Cdc31p specifically interacts with a short sequence within the carboxyl terminal half of Kar1p. The potential Cdc31p-binding sequence of Kar1p contains three acidic amino acids which are not found in calmodulin-binding peptides, explaining the different substrate specificities of Cdc31p and calmodulin. Cdc31p was also able to bind to the carboxy terminus of Nuflp/Spc110p, another component of the SPB (Kilmartin, J. V., S. L. Dyos, D. Kershaw, and J. T. Finch. 1993. J. Cell Biol. 123:1175-1184). The association of Kar1p with the spindle pole body was independent of Cdc31p. Cdc31p, on the other hand, was not associated with SPBs of kar1 cells.